We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Chilean drug manufacturers are pinning hopes on the production and export of genuine generics, as the market remains dominated by branded drugs and cheap copies.
Poland's National Health Fund (NFZ) estimates that drug reimbursement spending increased by PLN215mn (US$67.15mn) in the first half of 2005, an 8.2% increase on levels reported in 2004.
KV Pharmaceutical Company (NYSE: KVa/KVb) today announced that it has concluded a licensing agreement with Vitaflo Scandinavia AB for its two NDA products, Gynazole-1® (butocanzole nitrate 2% vaginal cream) for yeast infections from Candida, and Clindesse(TM) (clindamycin phosphate 2% vaginal cream) for bacterial vaginosis (BV).
Denmark's Novo Nordisk, the world's biggest maker of diabetes drugs, said on Monday it has entered into a collaboration with a privately-held Indian drug discovery company to work on a drug for metabolic disorders.
Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has received a grant of up to 2 Million from the SenterNovem Innovation Subsidy for Collaborative Projects program of the Dutch Ministry of Economic Affairs.
Inex Pharmaceuticals Corporation ("INEX"; TSX: IEX) announced today that at the close of business on Friday, September 16, 2005, it received a copy of a demand letter for repayment from the majority holder of the convertible debt issued by INEX's subsidiary,Inex International Holdings Ltd. ("Inex International").
According to the United Arab Emirates (UAE) health ministry, a long-awaited national health insurance scheme -- covering both nationals and expatriates -- will be implemented by the end of the year.